Considerations for RT-qPCR in molecular point of care testing devices

Considerations for RT-qPCR in molecular point of care testing devices

The COVID-19 pandemic has accelerated the uptake of point of care testing (POCT), with simple, user-administered tests becoming commonplace in schools, places of work and people’s homes. Antigen POCT has been pivotal in SARS-CoV-2 detection, particularly where reverse transcription PCR (RT-PCR) cannot be delivered in a timely manner. However, the use of antigen tests isn’t always appropriate due to variable sensitivity. RT-PCR – or RT-qPCR if using real-time detection – offers greater sensitivity and specificity. Leveraging this technology in POCT brings lab quality results to the point of need, providing rapid, accurate and actionable results to clinicians.

Read more

The BiosearchTech Blog

Most popular

Make your diagnostic workflows more adaptable

Posted on Mon, Jun 06, 2022 @ 12:47 PM

Since early 2020, diagnostic laboratories have had to manage patient sample quantities being in a state of flux. Demand ...
Read more

Topics: Coronavirus, DNA extraction, Pathogen detection

Streamlining diagnostic workflows for common respiratory diseases, such as SARS-CoV-2, influenza and RSV

Posted on Tue, Nov 30, 2021 @ 02:29 PM

A fourth wave of COVID-19 has already emerged in many countries and a newly classified variant of concern, Omicron ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2, Variants, Pathogen detection

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!